COPD Therapy
Links shared publicly online about this topic
PharmaTelevision - COPD Therapies, PTV News: May 12, 2010
pharmatelevision.com — “PharmaTelevision - COPD Therapies, PTV News: May 12, 2010” View full resource at pharmatelevision.com
Most Recently Shared on May 12, 2010 at 12:06 pm By:
COPD Therapies, PTV News: May 12, 2010: Galapagos and Roche expand their alliance to develop "smokers lung" drugs http://tinyurl.com/35m63w9
Nycomed wins EU approval for COPD therapy - FierceBiotech
fiercebiotech.com — “Despite being rebuffed by the FDA and its drug experts, Switzerland's Nycomed has won EU approval for Daxas, its new therapy to treat chronic obstructive pulmonary disorder. The approval will usher... Read more...” View full resource at fiercebiotech.com
Most Recently Shared on July 6, 2010 at 3:31 pm By:
RT @BiotechNews Nycomed wins EU approval for COPD therapy: Despite being rebuffed by the FDA... http://bit.ly/aFXFNj #Pharma #BioTech
Novartis wins FDA OK of low-dose COPD therapy - FierceBiotech
fiercebiotech.com — “Two years after the FDA originally stiff-armed Novartis on indacaterol inhalation powder regulators finally gave the COPD treatment a green light at a low dose. Word of the approval spread late on Read more...” View full resource at fiercebiotech.com
Most Recently Shared on July 5, 2011 at 12:45 pm By:
Novartis wins FDA OK of low-dose COPD therapy. http://bit.ly/kaYv10
Asthma and COPD Therapy | SYMBICORT® (budesonide/formoterol fumarate dihydrate)
symbicorttouchpoints.com — “Find information on asthma and COPD maintenance therapy with SYMBICORT (budesonide/formoterol fumarate dihydrate).” View full resource at symbicorttouchpoints.com
Most Recently Shared on October 8, 2010 at 3:26 pm By:
Symbicort (budesonide/formoterol fumarate dehydrate) [Highlight HEALTH Web Directory] http://ow.ly/19lVGt
Vectura Announces A New US Collaboration Agreement With A Leading International Pharmaceutical Company for the VR315 Combination Asthma/COPD Therapy - Drugs.com MedNews
drugs.com — “Chippenham, UK 3 August 2011 - Vectura Group plc ( Vectura LSE VEC) today announces that it has signed a US collaboration, development and license agreement wit” View full resource at drugs.com
Most Recently Shared on August 3, 2011 at 5:14 pm By:
Vectura Announces A New US Collaboration Agreement With A Leading International Pharmaceutical Company for... http://bit.ly/qUwLfb #drug
ingentaconnect Triple Therapy for the Management of COPD: A Review
ingentaconnect.com — “ingentaconnect Triple Therapy for the Management of COPD: A Review” View full resource at ingentaconnect.com
Most Recently Shared on June 9, 2011 at 12:26 pm By:
COPD: There is insufficient evidence to determine if triple therapy is superior to dual bronchodilator therapy http://bit.ly/kNGfkH
Respiratory Therapy Cave: What is severe COPD?
respiratorytherapycave.blogspot.com — “Respiratory Therapy Cave: What is severe COPD?” View full resource at respiratorytherapycave.blogspot.com
Most Recently Shared on March 26, 2010 at 2:06 pm By:
Physician's Weekly Article - Antibiotic Therapy & COPD Exacerbations
physweeklyarchives.com — “Physician's Weekly, your source for medical news, information on new drugs and devices, clinical updates, CME accreditation for radiology, emergency medicine, pediatrics, mammography, and anesthesia .” View full resource at physweeklyarchives.com
Most Recently Shared on September 9, 2010 at 9:25 pm By:
Antibiotic Therapy & COPD Exacerbations - A Massachusetts research group has found that early antibiotic administrat... http://ow.ly/18WgAy
Medical News: Triple Therapy Reduces COPD Exacerbations - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “For moderate-to-severe chronic obstructive pulmonary disease (COPD), a triple regimen of a long-acting β-agonist (LABA), an inhaled corticosteroid, and an antimuscarinic agent substantially cuts” View full resource at medpagetoday.com
Most Recently Shared on October 8, 2009 at 7:21 pm By:
Triple Therapy Reduces COPD Exacerbations (CME/CE) http://ow.ly/15TGWI
Triple-Therapy That Includes Tiotropium Reduces Death Rate in COPD
copd.about.com — “Triple-Therapy That Includes Tiotropium Reduces Death Rate in COPD” View full resource at copd.about.com
Most Recently Shared on August 25, 2011 at 8:54 pm By:
Deborah Trendel-Lead Triple-Therapy That Includes Tiotropium Reduces Death Rate in COPD: // <![CDATA[ "> // ]]>... http://t.co/4rCP7Ff
Combination Therapy Options in Stable COPD - QualityPoint Technologies
qualitypointtech.net — “Which long-acting muscarinic antagonist improves outcomes in COPD? U.S. Pharmacist” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 4:09 pm By:
Combination Therapy Options in Stable COPD: Which long-acting muscarinic antagonist improves outcomes in COPD? U.... http://bit.ly/bbOEAN
Combination Therapy Options in Stable COPD - QualityPoint Technologies
qualitypointtech.net — “Which long-acting muscarinic antagonist improves outcomes in COPD? U.S. Pharmacist (Source: Medscape Today Headlines)” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 5:42 pm By:
Combination Therapy Options in Stable COPD: Which long-acting muscarinic antagonist improves outcomes in COPD? U.S... http://bit.ly/cItCmJ
Respiratory Therapy Cave: The best Asthma, COPD blogs & websites of 2010
respiratorytherapycave.blogspot.com — “Respiratory Therapy Cave: The best Asthma, COPD blogs & websites of 2010” View full resource at respiratorytherapycave.blogspot.com
Most Recently Shared on December 30, 2009 at 4:19 pm By:
The best Asthma, COPD blogs of 2010: http://bit.ly/8ZCvyv via @addthis
Respiratory Therapy Cave: COPD more common than thought
respiratorytherapycave.blogspot.com — “Respiratory Therapy Cave: COPD more common than thought” View full resource at respiratorytherapycave.blogspot.com
Most Recently Shared on January 14, 2011 at 2:30 am By:
Reading: "COPD more common than thought"( http://twitthis.com/fz4fo4 )
Triple Therapy Halves Exacerbations in Moderate-to-Severe COPD
newswise.com — “Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting -agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.” View full resource at newswise.com
Most Recently Shared on October 8, 2009 at 5:36 am By:
Triple Therapy Halves Exacerbations in Moderate-to-Severe COPD http://bit.ly/1sqJ6C
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
PharmaTelevision
PharmaTelevision is the online TV channel for the pharmaceutical and biotechnology sectors, offering insights and feature interviews with industry leaders.
-
Richard G. Lanzara
Entrepreneurial Scientist and Pharmacologist interested in how our senses and receptors work and everything else that follows from that...
-
FierceBiotech
FierceBiotech's 140, written by Managing Editor Maureen Martino. Join the largest and most active biotech news readership in the world at FierceBiotech.com.
Advertisement

